Neural Plasticity in Multiple Sclerosis: The Functional and Molecular Background

Neural Plasticity

Volumn 2015, Issue , 2015, Pages

  Ksiazek Winiarek, Dominika Justyna ^a   Szpakowski, Piotr ^a   Glabinski, Andrzej ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BRAIN DERIVED NEUROTROPHIC FACTOR; CANNABINOID 1 RECEPTOR; INTERLEUKIN 1BETA; PLATELET DERIVED GROWTH FACTOR; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

BRAIN DAMAGE; CELL ACTIVATION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MICROGLIA; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REMYELINIZATION; REVIEW; ANIMAL; BRAIN; CONVALESCENCE; METABOLISM; PATHOPHYSIOLOGY;

AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; HUMANS; INTERLEUKIN-1BETA; MULTIPLE SCLEROSIS; NEURONAL PLASTICITY; PEPTIDE FRAGMENTS; PLATELET-DERIVED GROWTH FACTOR; RECEPTOR, CANNABINOID, CB1; RECOVERY OF FUNCTION;

EID: 84983094152     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2015/307175     Document Type: Review

References (152)

1. J. H. Noseworthy, C. Lucchinetti, M. Rodriguez, and B. G. Weinshenker, "Multiple sclerosis, " The New England Journal of Medicine, vol. 343, no. 13, pp. 938-952, 2000.
2. P. S. Sorensen, "Multiple sclerosis: pathophysiology revisited, " The Lancet Neurology, vol. 4, no. 1, pp. 9-10, 2005.
3. R. Nistico, F. Mori, M. Feligioni, F. Nicoletti, and D. Centonze, "Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis, " Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 369, no. 1633, Article ID 20130162, 2013.
4. M. V. Johnston, A. Ishida, W. N. Ishida, H. B. Matsushita, A. Nishimura, and M. Tsuji, "Plasticity and injury in the developing brain, " Brain & Development, vol. 31, no. 1, pp. 1-10, 2009.
5. B. Draganski, C. Gaser, G. Kempermann et al., "Temporal and spatial dynamics of brain structure changes during extensive learning, " The Journal of Neuroscience, vol. 26, no. 23, pp. 6314-6317, 2006.
6. E. Dayan and L. G. Cohen, "Neuroplasticity subserving motor skill learning, " Neuron, vol. 72, no. 3, pp. 443-454, 2011.
7. S. J. Martin and R. G. M. Morris, "New life in an old idea: the synaptic plasticity and memory hypothesis revisited, " Hippocampus, vol. 12, no. 5, pp. 609-636, 2002.
8. K.M. Jacobs and J. P. Donoghue, "Reshaping the cortical motor map by unmasking latent intracortical connections, " Science, vol. 251, no. 4996, pp. 944-947, 1991.
9. A. R. Cantrell and W. A. Catterall, "Neuromodulation of Na+ channels: an unexpected form of cellular plasticity, " Nature Reviews Neuroscience, vol. 2, no. 6, pp. 397-407, 2001.
10. G. Hess, C. D. Aizenman, and J. P. Donoghue, "Conditions for the induction of long-term potentiation in layer II/III horizontal connections of the rat motor cortex, " Journal of Neurophysiology, vol. 75, no. 5, pp. 1765-1778, 1996.
11. G. Hess and J. P. Donoghue, "Long-term depression of horizontal connections in rat motor cortex, " European Journal of Neuroscience, vol. 8, no. 4, pp. 658-665, 1996.
12. G. Martino, "How the brain repairs itself: new therapeutic strategies in inflammatory and degenerative CNS disorders, " The Lancet Neurology, vol. 3, no. 6, pp. 372-378, 2004.
13. G. Martino, S. Pluchino, L. Bonfanti, and M. Schwartz, "Brain regeneration in physiology and pathology: the immune signature driving therapeutic plasticity of neural stem cells, " Physiological Reviews, vol. 91, no. 4, pp. 1281-1304, 2011.
14. J. M. Frischer, S. Bramow, A. Dal-Bianco et al., "The relation between inflammation and neurodegeneration inmultiple sclerosis brains, " Brain, vol. 132, no. 5, pp. 1175-1189, 2009.
15. N. Evangelou, D. Konz, M. M. Esiri, S. Smith, J. Palace, and P. M. Matthews, "Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution inmultiple sclerosis, " Brain, vol. 123, part 9, pp. 1845-1849, 2000.
16. D. K. Crawford, M. Mangiardi, X. Xia, H. E. López-Valdés, and S. K. Tiwari-Woodruff, "Functional recovery of callosal axons following demyelination: a critical window, " Neuroscience, vol. 164, no. 4, pp. 1407-1421, 2009.
17. D.M. Mezzapesa, M. A. Rocca, M. Rodegher, G. Comi, andM. Filippi, "Functional cortical changes of the sensorimotor network are associated with clinical recovery inmultiple sclerosis, " Human Brain Mapping, vol. 29, no. 5, pp. 562-573, 2008.
18. P. Pantano, C. Mainero, D. Lenzi et al., "A longitudinal fMRI study on motor activity in patients with multiple sclerosis, " Brain, vol. 128, no. 9, pp. 2146-2153, 2005.
19. H. Reddy, S. Narayanan, P. M. Matthews et al., "Relating axonal injury to functional recovery in MS, " Neurology, vol. 54, no. 1, pp. 236-239, 2000.
20. A. Cifelli and P. M. Matthews, "Cerebral plasticity in multiple sclerosis: insights from fMRI, " Multiple Sclerosis, vol. 8, no. 3, pp. 193-199, 2002.
21. M. M. Schoonheim, J. J. G. Geurts, and F. Barkhof, "The limits of functional reorganization in multiple sclerosis, " Neurology, vol. 74, no. 16, pp. 1246-1247, 2010.
22. V. Tomassini, H. Johansen-Berg, L. Leonardi et al., "Preservation of motor skill learning in patients with multiple sclerosis, " Multiple Sclerosis, vol. 17, no. 1, pp. 103-115, 2011.
23. D. Zeller, K. Aufm Kampe, A. Biller et al., "Rapid-onset central motor plasticity in multiple sclerosis, " Neurology, vol. 74, no. 9, pp. 728-735, 2010.
24. J. R. Whitlock, A. J. Heynen, M. G. Shuler, and M. F. Bear, "Learning induces long-termpotentiation in the hippocampus, " Science, vol. 313, no. 5790, pp. 1093-1097, 2006.
25. F. Engert and T. Bonhoeffer, "Dendritic spine changes associated with hippocampal long-term synaptic plasticity, " Nature, vol. 399, no. 6731, pp. 66-70, 1999.
26. M.-H. Monfils, P. M. VandenBerg, J. A. Kleim, and G. C. Teskey, "Long-term potentiation induces expanded movement representations and dendritic hypertrophy in layer v of rat sensorimotor neocortex, " Cerebral Cortex, vol. 14, no. 5, pp. 586-593, 2004.
27. N. L. Desmond and W. B. Levy, "Changes in the numerical density of synaptic contacts with long-term potentiation in the hippocampal dentate gyrus, " The Journal of Comparative Neurology, vol. 253, no. 4, pp. 466-475, 1986.
28. E. Pastalkova, P. Serrano, D. Pinkhasova, E. Wallace, A. A. Fenton, and T. C. Sacktor, "Storage of spatial information by the maintenance mechanism of LTP, " Science, vol. 313, no. 5790, pp. 1141-1444, 2006.
29. M. de Roo, P. Klauser, and D. Muller, "LTP promotes a selective long-termstabilization and clustering of dendritic spines, " PLoS Biology, vol. 6, no. 9, article e219, 2008.
30. K. Morgen, N. Kadom, L. Sawaki et al., "Training-dependent plasticity in patients with multiple sclerosis, " Brain, vol. 127, no. 11, pp. 2506-2517, 2004.
31. F. Mori, H. Kusayanagi, C. G. Nicoletti, S. Weiss, M. G. Marciani, and D. Centonze, "Cortical plasticity predicts recovery from relapse in multiple sclerosis, " Multiple Sclerosis, vol. 20, no. 4, pp. 451-457, 2014.
32. F. Mori, R. Nistico, G. Mandolesi et al., "Interleukin-1 promotes long-term potentiation in patients with multiple sclerosis, " NeuroMolecular Medicine, vol. 16, no. 1, pp. 38-51, 2014.
33. S. Rossi, V. Studer, A. Moscatelli et al., "Opposite roles of NMDA receptors in relapsing and primary progressivemultiple sclerosis, " PLoS ONE, vol. 8, no. 6, Article ID e67357, 2013.
34. D. Centonze, L. Muzio, S. Rossi et al., "Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis, " Journal of Neuroscience, vol. 29, no. 11, pp. 3442-3452, 2009.
35. S. Rossi, L. Muzio, V. de Chiara et al., "Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis, " Brain, Behavior, and Immunity, vol. 25, no. 5, pp. 947-956, 2011.
36. G. Mandolesi, G. Grasselli, A. Musella et al., "GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis, " Neurobiology of Disease, vol. 46, no. 2, pp. 414-424, 2012.
37. R. Nistico, D. Mango, G. Mandolesi et al., "Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis, " PLoS ONE, vol. 8, no. 1, Article ID e54666, 2013.
38. R. Dutta, J. McDonough, X. Yin et al., "Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients, " Annals of Neurology, vol. 59, no. 3, pp. 478-489, 2006.
39. R. J. Clements, J. McDonough, and E. J. Freeman, "Distribution of parvalbumin and calretinin immunoreactive interneurons in motor cortex from multiple sclerosis post-mortem tissue, " Experimental Brain Research, vol. 187, no. 3, pp. 459-465, 2008.
40. R. Dantzer, J. C. OConnor, G. G. Freund, R. W. Johnson, and K. W. Kelley, "From inflammation to sickness and depression: when the immune systemsubjugates the brain, " Nature Reviews Neuroscience, vol. 9, no. 1, pp. 46-56, 2008.
41. M. Di Filippo, A. de Iure, V. Durante et al., "Synaptic plasticity and experimental autoimmune encephalomyelitis: implications for multiple sclerosis, " Brain Research, 2014.
42. U. Dirnagl, J. Klehmet, J. S. Braun et al., "Stroke-induced immunodepression: experimental evidence and clinical relevance, " Stroke, vol. 38, no. 2, supplement, pp. 770-773, 2007.
43. K. G. Haeusler, W. U. H. Schmidt, F. Föhring et al., "Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans, " CerebrovascularDiseases, vol. 25, no. 1-2, pp. 50-58, 2008.
44. L. Minichiello, F. Casagranda, R. S. Tatche et al., "Pointmutation in trkB causes loss of NT4-dependent neurons without major effects on diverse BDNF responses, " Neuron, vol. 21, no. 2, pp. 335-345, 1998.
45. I. Y. C. Liu, W. E. Lyons, L. A. Mamounas, and R. F. Thompson, "Brain-derived neurotrophic factor plays a critical role in contextual fear conditioning, " Journal of Neuroscience, vol. 24, no. 36, pp. 7958-7963, 2004.
46. C. S. Rex, C.-Y. Lin, E. A. Kramár, L. Y. Chen, C. M. Gall, and G. Lynch, "Brain-derived neurotrophic factor promotes long-term potentiation-related cytoskeletal changes in adult hippocampus, " Journal of Neuroscience, vol. 27, no. 11, pp. 3017-3029, 2007.
47. L. Y. Chen, C. S. Rex, Y. Sanaiha, G. Lynch, and C. M. Gall, "Learning induces neurotrophin signaling at hippocampal synapses, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 15, pp. 7030-7035, 2010.
48. M. Hofer, S. R. Pagliusi, A. Hohn, J. Leibrock, and Y.-A. Barde, "Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain, " The EMBO Journal, vol. 9, no. 8, pp. 2459-2464, 1990.
49. M. Kerschensteiner, E. Gallmeier, L. Behrens et al., "Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?" Journal of Experimental Medicine, vol. 189, no. 5, pp. 865-870, 1999.
50. G. R. Lewin and Y.-A. Barde, "Physiology of the neurotrophins, " Annual Review of Neuroscience, vol. 19, no. 1, pp. 289-317, 1996.
51. M. Besser and R. Wank, "Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells andTh1/Th2-polarized expression of their receptors, " Journal of Immunology, vol. 162, no. 11, pp. 6303-6306, 1999.
52. G. Moalem, R. Leibowitz-Amit, E. Yoles, F. Mor, I. R. Cohen, and M. Schwartz, "Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy, " Nature Medicine, vol. 5, no. 1, pp. 49-55, 1999.
53. H. Hammarberg, O. Lidman, C. Lundberg et al., "Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells, " Journal of Neuroscience, vol. 20, no. 14, pp. 5283-5291, 2000.
54. E. Hauben, U. Nevo, E. Yoles et al., "Autoimmune T cells as potential neuroprotective therapy for spinal cord injury, " The Lancet, vol. 355, no. 9200, pp. 286-287, 2000.
55. L. Studer, C. Spenger, R. W. Seiler, A. Othberg, O. Lindvall, and P. Odin, "Effects of brain-derived neurotrophic factor on neuronal structure of dopaminergic neurons in dissociated cultures of human fetal mesencephalon, " Experimental Brain Research, vol. 108, no. 2, pp. 328-336, 1996.
56. E. Tongiorgi, A. Sartori, G. Baj et al., "Altered serum content of brain-derived neurotrophic factor isoforms in multiple sclerosis, " Journal of the Neurological Sciences, vol. 320, no. 1-2, pp. 161-165, 2012.
57. I. Lundgaard, A. Luzhynskaya, J. H. Stockley et al., "Neuregulin and BDNF induce a switch to NMDA receptor-dependent myelination by oligodendrocytes, " PLoS Biology, vol. 11, no. 12, Article ID e1001743, 2013.
58. H. Schneider, F. Pitossi, D. Balschun, A. Wagner, A. del Rey, and H.O. Besedovsky, "Aneuromodulatory role of interleukin-1beta in the hippocampus, " Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 13, pp. 7778-7783, 1998.
59. C. Rachal Pugh, M. Fleshner, L. R. Watkins, S. F. Maier, and J.W. Rudy, "The immune system and memory consolidation: a role for the cytokine IL-1, "Neuroscience and Biobehavioral Reviews, vol. 25, no. 1, pp. 29-41, 2001.
60. R. M. Barrientos, M. G. Frank, A. M. Hein et al., "Time course of hippocampal IL-1 andmemory consolidation impairments in aging rats following peripheral infection, " Brain, Behavior, and Immunity, vol. 23, no. 1, pp. 46-54, 2009.
61. M. G. Frank, R. M. Barrientos, A. M. Hein, J. C. Biedenkapp, L. R. Watkins, and S. F. Maier, "IL-1RA blocks E. coli-induced suppression of Arc and long-termmemory in aged F344xBN F1 rats, " Brain, Behavior, and Immunity, vol. 24, no. 2, pp. 254-262, 2010.
62. F. P. Bellinger, S. Madamba, and G. R. Siggins, "Interleukin 1 inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus, " Brain Research, vol. 628, no. 1-2, pp. 227-234, 1993.
63. J. R. Erion, M. Wosiski-Kuhn, A. Dey et al., "Obesity elicits interleukin 1-mediated deficits in hippocampal synaptic plasticity, " The Journal of Neuroscience, vol. 34, no. 7, pp. 2618-2631, 2014.
64. D. Y. Kim, J. Hao, R. Liu, G. Turner, F.-D. Shi, and J. M. Rho, "Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis, " PLoS ONE, vol. 7, no. 5, Article ID e35476, 2012.
65. M. di Filippo, D. Chiasserini, F. Gardoni et al., "Effects of central and peripheral inflammation on hippocampal synaptic plasticity, " Neurobiology of Disease, vol. 52, pp. 229-236, 2013.
66. N. Prochnow, R. Gold, and A. Haghikia, "An electrophysiologic approach to quantify impaired synaptic transmission and plasticity in experimental autoimmune encephalomyelitis, " Journal of Neuroimmunology, vol. 264, no. 1-2, pp. 48-53, 2013.
67. E. J. Huang and L. F. Reichardt, "Neurotrophins: roles in neuronal development and function, " Annual Review of Neuroscience, vol. 24, pp. 677-736, 2001.
68. L. Tong, G. Aleph Prieto, E. A. Kramár et al., "Brain-derived neurotrophic factor-dependent synaptic plasticity is suppressed by interleukin-1 via p38mitogen-activated protein kinase, "The Journal of Neuroscience, vol. 32, no. 49, pp. 17714-17724, 2012.
69. K. Helmut, U.-K. Hanisch, M. Noda, and A. Verkhratsky, "Physiology of microglia, " Physiological Reviews, vol. 91, no. 2, pp. 461-553, 2011.
70. J. D. Cherry, J. A. Olschowka, and M. K. OBanion, "Neuroinflammation and M2 microglia: the good, the bad, and the inflamed, " Journal of Neuroinflammation, vol. 11, article 98, 2014.
71. M. Olah, S. Amor, N. Brouwer et al., "Identification of a microglia phenotype supportive of remyelination, " Gila, vol. 60, no. 2, pp. 306-321, 2012.
72. S. Amor, F. Puentes, D. Baker, and P. van der Valk, "Inflammation in neurodegenerative diseases, " Immunology, vol. 129, no. 2, pp. 154-169, 2010.
73. F.G. De Felice, P. T. Velasco, M. P. Lambert et al., "A oligomers induce neuronal oxidative stress through an N-methyl-Daspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine, " The Journal of Biological Chemistry, vol. 282, no. 15, pp. 11590-11601, 2007.
74. B. Ferguson, M. K. Matyszak, M. M. Esiri, and V. H. Perry, "Axonal damage in acute multiple sclerosis lesions, " Brain, vol. 120, no. 3, pp. 393-399, 1997.
75. B. D. Trapp, J. Peterson, R. M. Ransohoff, R. Rudick, S. Mörk, and L. Bö, "Axonal transection in the lesions of multiple sclerosis, " The New England Journal of Medicine, vol. 338, no. 5, pp. 278-285, 1998.
76. C. Haass, C. Kaether, G. Thinakaran, and S. Sisodia, "Trafficking and proteolytic processing of APP, " Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 5, Article ID a006270, 2012.
77. J. Kang, H.-G. Lemaire, A. Unterbeck et al., "The precursor of Alzheimers disease amyloid A4 protein resembles a cell-surface receptor, " Nature, vol. 325, no. 6106, pp. 733-736, 1987.
78. G. Yamin, "NMDA receptor-dependent signaling pathways that underlie amyloid -protein disruption of LTP in the hippocampus, " Journal of Neuroscience Research, vol. 87, no. 8, pp. 1729-1736, 2009.
79. S. Li, S. Hong, N. E. Shepardson, D. M. Walsh, G. M. Shankar, andD. Selkoe, "Soluble oligomers of amyloid protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake, " Neuron, vol. 62, no. 6, pp. 788-801, 2009.
80. A. Itoh, T. Akaike, M. Sokabe et al., "Impairments of long-term potentiation in hippocampal slices of -amyloid-infused rats, " European Journal of Pharmacology, vol. 382, no. 3, pp. 167-175, 1999.
81. Q.-S. Chen, W.-Z. Wei, T. Shimahara, and C.-W. Xie, "Alzheimer amyloid -peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus, " Neurobiology of Learning and Memory, vol. 77, no. 3, pp. 354-371, 2002.
82. K. Parameshwaran, C. Sims, P. Kanju et al., "Amyloid -peptide A1-42 but not A 1-40 attenuates synaptic AMPA receptor function, " Synapse, vol. 61, no. 6, pp. 367-374, 2007.
83. L. Liu, T. P. Wong, M. F. Pozza et al., "Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity, " Science, vol. 304, no. 5673, pp. 1021-1024, 2004.
84. H. Hsieh, J. Boehm, C. Sato et al., "AMPAR removal underlies A-induced synaptic depression and dendritic spine loss, " Neuron, vol. 52, no. 5, pp. 831-843, 2006.
85. L. Mucke and D. J. Selkoe, "Neurotoxicity of amyloid betaprotein: synaptic and network dysfunction, " Cold SpringHarbor Perspectives in Medicine, vol. 2, no. 7, Article ID a006338, 2012.
86. G. M. Shankar, S. Li, T. H. Mehta et al., "Amyloid-protein dimers isolated directly from Alzheimers brains impair synaptic plasticity and memory, " Nature Medicine, vol. 14, no. 8, pp. 837-842, 2008.
87. M. J. Rowan, I. Klyubin, Q. Wang, N. W. Hu, and R. Anwyl, "Synaptic memory mechanisms: Alzheimers disease amyloid beta-peptide-induced dysfunction, " Biochemical Society Transactions, vol. 35, part 5, pp. 1219-1223, 2007.
88. R. Furlan, E. Brambilla, F. Sanvito et al., "Vaccination with amyloid-peptide induces autoimmune encephalomyelitis in C57/BL6 mice, " Brain, vol. 126, no. 2, pp. 285-291, 2003.
89. J. L. Grant, E. E. B. Ghosn, R. C. Axtell et al., "Reversal of paralysis and reduced inflammation from peripheral administration of -amyloid in TH1 and TH17 versions of experimental autoimmune encephalomyelitis, " Science Translational Medicine, vol. 4, no. 145, Article ID 145ra105, 2012.
90. M. P. Kurnellas, C. M. Adams, R. A. Sobel, L. Steinman, and J. B. Rothbard, "Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation, " Science Translational Medicine, vol. 5, no. 179, Article ID 179ra42, 2013.
91. K. Hein NeeMaier, A. Köhler, R. Diem et al., "Biological markers for axonal degeneration in CSF and blood of patients with the first event indicative for multiple sclerosis, " Neuroscience Letters, vol. 436, no. 1, pp. 72-76, 2008.
92. M. Vališ, R. Taláb, P. Stourač, C. Andrýs, and J. Masopust, "Tau protein, phosphorylated tau protein and beta-amyloid42 in the cerebrospinal fluid of multiple sclerosis patients, " Neuroendocrinology Letters, vol. 29, no. 6, pp. 971-976, 2008.
93. L. Szalardy, D. Zadori, M. Simu, K. Bencsik, L. Vecsei, and P. Klivenyi, "Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potentialmarker of clinical severity, " Journal of the Neurological Sciences, vol. 331, no. 1-2, pp. 38-42, 2013.
94. S. Rossi, R. Mancino, A. Bergami et al., "Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis, " Multiple Sclerosis, vol. 17, no. 11, pp. 1301-1312, 2011.
95. K. Augutis, M. Axelsson, E. Portelius et al., "Cerebrospinal fluid biomarkers of -amyloid metabolism in multiple sclerosis, " Multiple Sclerosis, vol. 19, no. 5, pp. 543-552, 2013.
96. F. Mori, S. Rossi, G. Sancesario et al., "Cognitive and cortical plasticity deficits correlate with altered amyloid-[beta] CSF levels in multiple sclerosis, " Neuropsychopharmacology, vol. 36, no. 3, pp. 559-568, 2011.
97. J. Bellmann-Strobl, J. Wuerfel, O. Aktas et al., "Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis, " Neurology, vol. 73, no. 20, pp. 1624-1627, 2009.
98. H. Braak, H. Zetterberg, K. del Tredici, and K. Blennow, "Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid- changes occur before increases of tau in cerebrospinal fluid, " Acta Neuropathologica, vol. 126, no. 5, pp. 631-641, 2013.
99. K. Blennow, H. Zetterberg, and A. M. Fagan, "Fluid biomarkers in Alzheimer disease, " Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 9, Article ID a006221, 2012.
100. H. Englund, M. D. Gunnarsson, R. M. Brundin et al., "Oligomerization partially explains the lowering of Abeta42 in Alzheimers disease cerebrospinal fluid, " Neurodegenerative Diseases, vol. 6, no. 4, pp. 139-147, 2009.
101. K. Kierdorf, Y. Wang, and H. Neumann, "Immune-mediated CNS damage, " Results and Problems in Cell Differentiation, vol. 51, pp. 173-196, 2010.
102. M. Schwartz, G. Moalem, R. Leibowitz-Amit, and I. R. Cohen, "Innate and adaptive immune responses can be beneficial for CNS repair, " Trends in Neurosciences, vol. 22, no. 7, pp. 259-299, 1999.
103. M. Kerschensteiner, C. Stadelmann, G. Dechant, H. Wekerle, and R. Hohlfeld, "Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases, " Annals of Neurology, vol. 53, no. 3, pp. 292-304, 2003.
104. A. Rottlaender, H. Villwock, K. Addicks, and S. Kuerten, "Neuroprotective role of fibroblast growth factor-2 in experimental autoimmune encephalomyelitis, " Immunology, vol. 133, no. 3, pp. 370-378, 2011.
105. E.D. Ponomarev, L. P. Shriver, K. Maresz, J. Pedras-Vasconcelos, D. Verthelyi, and B. N. Dittel, "GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis, " Journal of Immunology, vol. 178, no. 1, pp. 39-48, 2007.
106. E. E. Frost, J. A. Nielsen, T. Q. Le, and R. C. Armstrong, "PDGF and FGF2 regulate oligodendrocyte progenitor responses to demyelination, " Journal of Neurobiology, vol. 54, no. 3, pp. 457-472, 2003.
107. A. Erlandsson, M. Enarsson, and K. Forsberg-Nilsson, "Immature neurons from CNS stem cells proliferate in response to platelet-derived growth factor, " Journal of Neuroscience, vol. 21, no. 10, pp. 3483-3491, 2001.
108. A. C. Vana, N. C. Flint, N. E. Harwood, T. Q. Le, M. Fruttiger, and R. C. Armstrong, "Platelet-derived growth factor promotes repair of chronically demyelinated white matter, " Journal of Neuropathology and Experimental Neurology, vol. 66, no. 11, pp. 975-988, 2007.
109. B. P. Williams, J. K. Park, J.A. Alberta et al., "APDGF-regulated immediate early gene response initiates neuronal differentiation in ventricular zone progenitor cells, " Neuron, vol. 18, no. 4, pp. 553-562, 1997.
110. B. Cheng and M. P. Mattson, "PDGFs protect hippocampal neurons against energy deprivation and oxidative injury: evidence for induction of antioxidant pathways, " Journal of Neuroscience, vol. 15, no. 11, pp. 7095-7104, 1995.
111. F. Mori, S. Rossi, S. Piccinin et al., "Synaptic plasticity and PDGF signaling defects underlie clinical progression in multiple sclerosis, " The Journal of Neuroscience, vol. 33, no. 49, pp. 19112-19119, 2013.
112. F. Mori, C. G. Nicoletti, S. Rossi et al., "Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis, " NeuroMolecular Medicine, vol. 16, no. 2, pp. 490-498, 2014.
113. F. Peng, H. Yao, X. Bai et al., "Platelet-derived growth factormediated induction of the synaptic plasticity gene Arc/Arg3.1, " Journal of Biological Chemistry, vol. 285, no. 28, pp. 21615-21624, 2010.
114. M. H. Harirchian, A. H. Tekieh, A. Modabbernia et al., "Serum and CSF PDGF-AA and FGF-2 in relapsing-remitting multiple sclerosis: a case-control study, " European Journal of Neurology, vol. 19, no. 2, pp. 241-247, 2012.
115. M. Sasahara, J.W.U. Fries, E.W. Raines et al., "PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model, " Cell, vol. 64, no. 1, pp. 217-227, 1991.
116. D. Gozal, N. Simakajornboon, M. A. Czapla et al., "Brainstem activation of platelet-derived growth factor-receptormodulates the late phase of the hypoxic ventilatory response, " Journal of Neurochemistry, vol. 74, no. 1, pp. 310-319, 2000.
117. R. H. Bonow, S. Äid, Y. Zhang, K. G. Becker, and F. Bosetti, "The brain expression of genes involved in inflammatory response, the ribosome, and learning and memory is altered by centrally injected lipopolysaccharide in mice, " Pharmacogenomics Journal, vol. 9, no. 2, pp. 116-126, 2009.
118. J. F. Guzowski, B. Setlow, E. K. Wagner, and J. L. McGaugh, "Experience-dependent gene expression in the rat hippocampus after spatial learning: a comparison of the immediate-early genes Arc, c-fos, and zif268, " The Journal of Neuroscience, vol. 21, no. 14, pp. 5089-5098, 2001.
119. Y. Ishii, T. Oya, L. Zheng et al., "Mouse brains deficient in neuronalPDGF receptor-develop normally but are vulnerable to injury, " Journal of Neurochemistry, vol. 98, no. 2, pp. 588-600, 2006.
120. T. E. Bartlett and Y. T. Wang, "The intersections of NMDARdependent synaptic plasticity and cell survival, " Neuropharmacology, vol. 74, pp. 59-68, 2013.
121. D. Piomelli, "The molecular logic of endocannabinoid signalling, " Nature ReviewsNeuroscience, vol. 4, no. 11, pp. 873-884, 2003.
122. G. Marsicano and B. Lutz, "Neuromodulatory functions of the endocannabinoid system, " Journal of Endocrinological Investigation, vol. 29, supplement 3, pp. 27-46, 2006.
123. C. W. Vaughan and M. J. Christie, "Retrograde signalling by endocannabinoids, " Handbook of Experimental Pharmacology, vol. 168, pp. 367-383, 2005.
124. T. Harkany, E. Keimpema, K. Barabás, and J. Mulder, "Endocannabinoid functions controlling neuronal specification during brain development, " Molecular and Cellular Endocrinology, vol. 286, supplement 1, no. 1-2, pp. S84-S90, 2008.
125. D. M. Lovinger, "Presynaptic modulation by endocannabinoids, " Handbook of Experimental Pharmacology, vol. 184, pp. 435-477, 2008.
126. V. Chevaleyre, K. A. Takahashi, and P. E. Castillo, "Endocannabinoid-mediated synaptic plasticity in the CNS, " Annual Review of Neuroscience, vol. 29, pp. 37-76, 2006.
127. G. Pryce, Z. Ahmed, D. J. R. Hankey et al., "Cannabinoids inhibit neurodegeneration in models of multiple sclerosis, " Brain, vol. 126, part 10, pp. 2191-2202, 2003.
128. L. Mestre, F. Correa, A. Arévalo-Martín et al., "Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis, " Journal of Neurochemistry, vol. 92, no. 6, pp. 1327-1339, 2005.
129. L. Mestre, F. Docagne, F. Correa et al., "A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules, " Molecular and Cellular Neuroscience, vol. 40, no. 2, pp. 258-266, 2009.
130. J. L. Croxford, G. Pryce, S. J. Jackson et al., "Cannabinoidmediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis, " Journal of Neuroimmunology, vol. 193, no. 1-2, pp. 120-129, 2008.
131. M. Zhang, B. R. Martin, M. W. Adler et al., "Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke, " Journal of Neuroimmune Pharmacology, vol. 4, no. 2, pp. 249-259, 2009.
132. D. Centonze, M. Bari, S. Rossi et al., "The endocannabinoid system is dysregulated inmultiple sclerosis and in experimental autoimmune encephalomyelitis, " Brain, vol. 130, no. 10, pp. 2543-2553, 2007.
133. D. Baker, G. Pryce, J. L. Croxford et al., "Endocannabinoids control spasticity in a multiple sclerosis model, " The FASEB Journal, vol. 15, no. 2, pp. 300-302, 2001.
134. M. Webb, L. Luo, J. Y. Ma, and C.-S. Tham, "Genetic deletion of fatty acid amide hydrolase results in improved long-term outcome in chronic autoimmune encephalitis, " Neuroscience Letters, vol. 439, no. 1, pp. 106-110, 2008.
135. A. Musella, H. Sepman, G. Mandolesi et al., "Pre-and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis, " Neuropharmacology, vol. 79, pp. 567-572, 2014.
136. W. A. Devane, F. A. Dysarz III, M. R. Johnson, L. S. Melvin, and A. C. Howlett, "Determination and characterization of a cannabinoid receptor in rat brain, " Molecular Pharmacology, vol. 34, no. 5, pp. 605-613, 1988.
137. A. C. Howlett, "Reverse pharmacology applied to the cannabinoid receptor, " Trends in Pharmacological Sciences, vol. 11, no. 10, pp. 395-397, 1990.
138. S. Rossi, R. Furlan, V. D. Chiara et al., "Cannabinoid CB1 receptors regulate neuronal TNF-effects in experimental autoimmune encephalomyelitis, " Brain, Behavior, and Immunity, vol. 25, no. 6, pp. 1242-1248, 2011.
139. S. Rossi, C. Motta, V. Studer et al., "Tumor necrosis factor is elevated in progressivemultiple sclerosis and causes excitotoxic neurodegeneration, " Multiple Sclerosis, vol. 20, no. 3, pp. 304-312, 2014.
140. D. Centonze, F. Mori, G. Koch et al., "Lack of effect of cannabisbased treatment on clinical and laboratorymeasures inmultiple sclerosis, "Neurological Sciences, vol. 30, no. 6, pp. 531-534, 2009.
141. P. Zhao, D. Leonoudakis, M. E. Abood, and E. C. Beattie, "Cannabinoid receptor activation reduces TNFalpha-Induced surface localization of AMPAR-type glutamate receptors and excitotoxicity, " Neuropharmacology, vol. 58, no. 2, pp. 551-558, 2010.
142. M. de Roo, P. Klauser, P. M. Garcia, L. Poglia, and D. Muller, "Chapter 11 Spine dynamics and synapse remodeling during LTP andmemory processes, " Progress in Brain Research, vol. 169, pp. 199-207, 2008.
143. J. Kesselring and S. Beer, "Symptomatic therapy and neurorehabilitation inmultiple sclerosis, " The Lancet Neurology, vol. 4, no. 10, pp. 643-652, 2005.
144. A. Novotna, J. Mares, S. Ratcliffe et al., "A randomized, double-blind, placebo-controlled, parallel-group, enricheddesign study of nabiximols (Sativex), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis, " European Journal of Neurology, vol. 18, no. 9, pp. 1122-1131, 2011.
145. V. De Chiara, F. Errico, A. Musella et al., "Voluntary exercise and sucrose consumption enhance cannabinoid cb1 receptor sensitivity in the striatum, " Neuropsychopharmacology, vol. 35, no. 2, pp. 374-387, 2010.
146. S. Rossi, R. Furlan, V. De Chiara et al., "Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis, " Neurobiology of Disease, vol. 36, no. 1, pp. 51-59, 2009.
147. F. Mori, C. Ljoka, C. G. Nicoletti et al., "CB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis, " Neurology: Neuroimmunology & Neuroinflammation, vol. 1, no. 4, article e48, 2014.
148. L. Cutando, A. Busquets-Garcia, E. Puighermanal et al., "Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure, "The Journal of Clinical Investigation, vol. 123, no. 7, pp. 2816-2831, 2013.
149. S. Rossi, F. Buttari, V. Studer et al., "The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis, " Multiple Sclerosis, vol. 17, no. 3, pp. 281-288, 2011.
150. E. Ramil, A. J. Sánchez, P. González-Pérez et al., "The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain, " Multiple Sclerosis, vol. 16, no. 2, pp. 139-146, 2010.
151. N. Madroñal, A. Gruart, O. Valverde, I. Espadas, R. Moratalla, and J. M. Delgado-García, "Involvement of cannabinoid CB1 receptor in associative learning and in hippocampal CA3-CA1 synaptic plasticity, " Cerebral Cortex, vol. 22, no. 3, pp. 550-566, 2012.
152. S. Dubreucq, A. Durand, I. Matias et al., "Ventral tegmental area cannabinoid type-1 receptors control voluntary exercise performance, " Biological Psychiatry, vol. 73, no. 9, pp. 895-903, 2013.